C148 - Developing the Treatments of Tomorrow II: Clinical Trials in Neurology

Event Time: Tuesday April 25, 2017 3:30 pm to 5:30 pm
Topic(s): Research Methodology, Education, and History
Director(s): Jeffrey Gelfand MD, MAS, FAAN
Description: This program will provide an overview and update of the science of clinical trials for practicing neurologists, researchers, and trainees. Clinical trials are the bedrock of evidence-based neurology and one of the greatest methodological innovations of modern medicine. Academic, industry, and regulatory representatives will provide an overview of clinical trials, discuss approaches to optimize success, review advances in trial design and implementation, and address statistical and regulatory considerations. Faculty will also facilitate a discussion with the attendees. A companion session will address the preclinical drug development pipeline, translation of research breakthroughs to the clinic, and first-in-human studies. This program complements C132: Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Human, but covers independent topics.
Completion Message: Participants should be able to understand differences between early and late stage clinical trials and their role in the drug development pipeline, assess the strengths and weaknesses of various clinical trial designs, use appropriate statistical approaches, and understand regulatory issues.
CME Credits: 2
Core Competencies: Medical Knowledge, Systems-Based Practice

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses